Serial Testing of Tumor-Derived DNA in Cerebrospinal Fluid (CSF) to Monitor Leptomeningeal Disease and Assess Therapeutic Response in Lung Cancer Metastasis to the Central Nervous System – A Case Report

Annals of Clinical Case Reports, October 2025

Analytical validation of the Belay Vantage™ assay for evaluation of MGMT promoter methylation using enzymatically converted tumorDNA from cerebrospinal fluid (CSF)

Cancer Genetics, June 2025

Analytical Validation and Clinical Sensitivity of the Belay Summit assay for the detection of DNA variants in cerebrospinal fluid (CSF) of primary and metastatic CNS cancer

Journal of Molecular Diagnostics, 2025

Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid (CSF)

Cell Reports Medicine, August 2023

Detection of low-frequency DNA variants by targeted sequencing of the Watson and Crick strands

Nature Biotechnology, October 2021

Detection of tumor-derived DNA in cerebrospinal fluid (CSF) of patients with primary tumors of the brain and spinal cord

Proceedings of the National Academy of Sciences (PNAS), August 2015

Detection of circulating tumor DNA in early- and late-stage human malignancies

Science Translational Medicine, 2014

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

PNAS, March 2013

Mutations in CIC and FUBP1 Contribute to Human Oligodendroglioma

Science, August 2011

Demonstrating the clinical utility of genomic profiling using cerebrospinal fluid to inform management of central nervous system tumors – a meta analysis of the literature

The Journal of Liquid Biopsy, July 2025

Molecular Analysis of Cerebrospinal Fluid Tumor-Derived DNA to Aid in the Diagnosis and Targeted Treatment of Breast Cancer Brain Metastasis

Diseases, October 2025

Analysis of cerebrospinal fluid (CSF) tumor-derived DNA to obviate biopsy of IDH-mutant brainstem glioma in an adult

The Journal of Liquid Biopsy, September 2025

Choroid plexus metastasis of a renal cell carcinoma—A case report and review of the literature

Neuro-Oncology Advances, January-December 2025

Cerebrospinal Fluid based liquid biopsy to inform diagnosis and management of Leptomeningeal Metastases in EGFR-Mutant Lung Cancer – A Case Report

European Society of Medicine, June 2025

Detection and quantification of rare mutations with massively parallel sequencing

The Proceedings of the National Academy of Sciences, June 2011

The genetic landscape of the childhood cancer medulloblastoma

Science, January 2011

Detection of rare mutations, copy number alterations, and methylation in the same template DNA molecules

The Proceedings of the National Academy of Sciences, August 2023